Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • John Mendelsohn,...

    John Mendelsohn, former MD Anderson president, dead

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-10T09:15:30+05:30  |  Updated On 10 Jan 2019 9:15 AM IST
    John Mendelsohn, former MD Anderson president, dead




    Mendelsohn, who was the president emeritus of prestigious Texas MD Anderson Cancer Centre, was diagnosed of glioblastoma 15 months ago and succumbed to the aggressive brain cancer at his home on Tuesday, a statement from the hospital officials said.

    Houston: John Mendelsohn, a pioneering physician-scientist in the arena of cancer treatment and a strong advocate of traditional Indian medicine system Yoga, died here on Tuesday. He was 82.

    Mendelsohn, who was the president emeritus of prestigious Texas MD Anderson Cancer Centre, was diagnosed of glioblastoma 15 months ago and succumbed to the aggressive brain cancer at his home on Tuesday, a statement from the hospital officials said.

    Known to be close to the Indian-Americans, Mendelsohn was a pioneer in embracing alternative medicines and Yoga.

    His vision helped make yoga a household name across the US and worldwide.

    "Dr Mendelsohn vision helped make yoga a household name across the US and worldwide. The Integrative Medicine Department that he started has helped so many patients at MD Anderson. It was so successful that other institutions such as Harvard and Stanford started research on alternative medicines. MD Anderson was the first to receive a USD 5 million yoga research grant," Durga Agrawal, founding president of Indo-American Chamber of Greater Houston and a close friend of Mendelsohn, said.

    A molecular biologist, Mendelsohn also conducted some of the earliest research in targeted therapy, a type of treatment that more precisely identifies and attacks cancer cells, the Houston Chronicle reported.

    Mendelsohn demonstrated how growth factors regulate the proliferation of cancer cells through a process that activates receptors on the cell surfaces.

    His work was the basis of personalised medicine, in which treatment is tailored to the individual patient.

    Mendelsohn's work was also a precursor to that of MD Anderson's Jim Allison, who recently won the Nobel Prize for his cancer research.





    Also Read: AIIA signs MoU with IIT to boost research in traditional medicine

    Andersons Jim Allisonbrain cancercancercancer treatmentDr MendelsohnGlioblastomaHOUSTONHouston ChronicleIndian Americans MendelsohnIndian medicine system YogaJohn MendelsohnJohn Mendelsohn deadNobel PrizeTexas MD Anderson Cancer CentreTraditional MedicinetreatmentUSYoga
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok